SCHEMBL4796523

SCHEMBL4796523

[CH2][CH]Nc1ccn2ncc(-c3ccc(OC)nc3)c2n1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FYN P06241 6/20 0.56
TGFBR2 P37173 3/20 0.54
ACVR2A P27037 3/20 0.54
TGFBR1 P36897 2/20 0.54
JAK2 O60674 1/20 0.46
PIK3CG P48736 3/20 0.43
PIM1 P11309 3/20 0.40
RET P07949 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PIM2 Q9P1W9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4595121 0.83 FYN (0.77) FYNTGFBR2ACVR2ATGFBR1JAK2
SCHEMBL4727573 0.82 FYN (0.60) FYNTGFBR2ACVR2ATGFBR1PIK3CG
SCHEMBL4338930 0.81 RET (0.59) FYNTGFBR2ACVR2ATGFBR1PIM1
SCHEMBL4339409 0.80 FYN (0.73) FYNTGFBR2ACVR2ATGFBR1JAK2
SCHEMBL4836241 0.80 FYN (0.60) FYNTGFBR2ACVR2ATGFBR1PIK3CG
SCHEMBL4330159 0.78 PIK3CG (0.65) FYNTGFBR2ACVR2ATGFBR1JAK2
SCHEMBL4694423 0.78 PIK3CG (0.69) FYNTGFBR2ACVR2ATGFBR1PIK3CG
SCHEMBL4339522 0.77 FYN (0.78) FYNTGFBR2ACVR2ATGFBR1JAK2
SCHEMBL4344737 0.76 FYN (0.67) FYNTGFBR2ACVR2ATGFBR1PIK3CG
SCHEMBL4334171 0.76 FYN (0.78) FYNTGFBR2ACVR2ATGFBR1PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008025822-A1 DIAZOLODIAZINE DERIVATIVES AS KINASE INHIBITORS CELLZOME LIMITED (GB) 2008-03-06 WO claimed
WO-2008025822-A1 DIAZOLODIAZINE DERIVATIVES AS KINASE INHIBITORS CELLZOME LIMITED (GB) 2008-03-06 WO disclosed